For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260413:nRSM1572Aa&default-theme=true
RNS Number : 1572A Alpha Growth PLC 13 April 2026
REACH: non-regulatory announcement
Alpha Growth plc
("Alpha" or the "Company")
Alpha Longevity Management launches U.S. specialty finance strategy for
Japanese institutional investors, led by former members of Nikko Asset
Management's team.
Alpha Growth plc, a leading global specialist in longevity assets,
insurance-linked strategies, and alternative yield solutions, today announced
that its asset management subsidiary, Alpha Longevity Management Ltd ("ALM"),
has launched a U.S.-focused specialty finance and uncorrelated alternatives
strategy for Japanese institutional investors, deepening the firm's strategic
expansion across Asia's institutional capital markets.
The strategy is led by a former senior member of Nikko Asset Management
(Amova) investment team, Andre Severino, ALM's Senior Managing Director and
Chief Investment Officer, alongside Charlie Devin-Smith, ALM's Managing
Director and Senior Portfolio Manager, combining deep expertise in global
fixed income, derivatives, liquidity management, and Japanese institutional
solutions mandates. As previously stated, both executives previously held
senior investment roles within Nikko Asset Management's London-based global
fixed income platform, where they were instrumental in managing
multi-billion-dollar global bond strategies and supporting the growth of the
firm's Japanese institutional franchise.
The strategy will be offered through the Alpha Omni Alternative Global Fund, a
sub-fund of the Alpha Omni Funds ICAV, and has been specifically developed to
address rising demand among Japanese pensions, insurers, trust banks, and
family office allocators for stable income-oriented alternatives with low
correlation to traditional fixed income and public market beta exposures.
The portfolio focuses on U.S. asset-based specialty finance opportunities,
with particular emphasis on litigation-linked pre-settlement finance,
structured settlement receivables, royalties, and other esoteric contractual
cash-flow streams. The strategy targets gross annual returns above 10%, with
return drivers designed to remain structurally independent from duration risk,
credit spread volatility, and listed market directionality.
This positioning is especially relevant for Japanese institutional portfolios
as allocators adapt to a higher-rate global environment, more volatile policy
paths, and reduced certainty around conventional sovereign and public credit
allocations.
Andre brings more than 25 years of international investment experience across
fixed income, currencies, and derivatives. During his tenure at Nikko Asset
Management, he served as Head of Global Fixed Income, overseeing the flagship
global bond strategy while contributing materially to the expansion of
Japanese institutional solutions, including the development of progressive
outcome-oriented mandates for large-scale clients.
Charlie adds further depth in portfolio implementation and liquidity
management, having previously managed a $4 billion global bond fund and
contributed to a broader $16 billion platform with a focus on quantitative and
liquidity strategies.
By leveraging contractual specialty finance cash flows and event-driven
receivables, the strategy seeks to provide diversified return sources distinct
from public credit, equity beta, and traditional macro-sensitive fixed income
exposures, offering Japanese institutional investors a differentiated sleeve
for resilient portfolio income and alternative risk premia.
Japan remains a core strategic fundraising market for ALM as the firm
continues to build long-term relationships across Asia's consultant, pension,
insurer, and trust-bank ecosystem through differentiated private market and
insurance-adjacent investment solutions.
The Alpha Omni Funds ICAV, domiciled in Ireland and authorized by the Central
Bank of Ireland, serves as Alpha's regulated cross-border institutional
platform, providing access to diversified portfolios spanning life
settlements, annuities, private credit, and alternative yield opportunities.
Alpha Longevity Management Ltd - Andre Severino as@algwplc.com (mailto:as@algwplc.com)
Charlie Devin-Smith cds@algwplc.com (mailto:cds@algwplc.com)
UK Investor Relations - Mark Treharne ir@algwplc.com (mailto:ir@algwplc.com)
About Alpha Growth plc
Alpha Growth plc is a global financial services specialist focused on
longevity assets, insurance-linked investments, and institutional wealth
solutions. Through Alpha Longevity Management Ltd, the firm delivers
differentiated alternatives, uncorrelated investment strategies, and specialty
finance solutions to institutional investors globally, with Japan representing
an increasingly important strategic growth market.
About Alpha Longevity Management Ltd
Alpha Longevity Management Ltd, a subsidiary of Alpha Growth plc, is a
Bermuda-based asset manager focused on longevity and esoteric asset
strategies. Through its regulated fund structures in Bermuda and Ireland, the
firm provides institutional and high-net-worth investors with access to
uncorrelated, long-term investment opportunities across insurance-linked,
private credit, and alternative yield markets.
Disclaimer
This news release relates to the Alpha Omni Funds ICAV and its sub-fund Alpha
Alternative Global Fund. The ICAV is an alternative investment fund domiciled
in Ireland and authorised by the Central Bank of Ireland as a qualifying
investor alternative investment fund. The ICAV is managed in accordance with
the Alternative Investment Fund Managers Directive. Investment management
services are provided by Alpha Longevity Management Ltd, licensed by the
Bermuda Monetary Authority and authorised by the Central Bank of Ireland to
act as a non-EU Investment Manager to Irish authorised investment funds.
This communication is provided for information purposes only and does not
constitute an offer, recommendation or invitation to subscribe for, or a
solicitation to purchase, any interests in the Fund. Any such offer or
solicitation may be made only in accordance with applicable laws and
regulations and on the basis of the Fund's offering documents.
This communication is directed solely at professional investors and qualifying
investors and is not intended for distribution to retail investors. This
communication is not intended for distribution to, or use by, any person or
entity in any jurisdiction where such distribution would be contrary to
applicable law or regulation.
***END***
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NRAFFFEFSIIFLIR
Copyright 2019 Regulatory News Service, all rights reserved